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Abstract 
Epidemiological studies report high rates of schizophrenia in individuals with intellectual disability 
(ID). However, this subject has not been reviewed systematically. We aim to review studies that 
report the prevalence of nonaffective psychosis in a population with ID and estimate the prevalence 
of schizophrenia in this population. We performed a literature search using the PsychINFO, MEDLINE 
and EMBASE (from inception to 2 October 2014). We performed a manual search of citations from 
relevant papers identified through the databases. We identified 887 titles and after screening 
abstracts, identified 60 full-text articles. We identified 25 studies with 27 datasets for inclusion in the 
systematic review and meta-analysis. The prevalence rate was at least three times higher than the 
general population. There was a wide variation in the methodology, setting and sample size of the 
studies. Only one study reported a prevalence rate lower than the general population. The 
prevalence of psychosis in a population with ID is at least three times higher than that in the general 
population. 
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Introduction 
Over the last five decades, epidemiological studies have reported high rates of schizophrenia in 
individuals with intellectual disability (ID) compared with that reported in the general population 
(Penrose, 1938; Reid, 1972; Cooper et al., 2007). The relationship between ID and schizophrenia is 
complex. A number of studies suggest that individuals who later develop schizophrenia have lower 
IQ scores (Jones et al., 1994; David et al., 1997; Kremen et al., 1998; Davidson et al., 1999; Cannon et 
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al., 2000; Zammit et al., 2004; Bilder et al., 2006; Woodberry et al., 2008). These individuals score 
about 0.5 SD below normal (Woodberry et al., 2008). The evidence also suggests that IQ scores 
decline in adolescents who later develop psychosis (Kremen et al., 1998; Fuller et al., 2002) and that 
the greatest deficit is just before the onset of illness (Rabinowitz et al., 2000; Gunnell et al., 2002). It 
has also been suggested that IQ scores tend to deteriorate during transition to illness (Cosway et al., 
2000; Caspi et al., 2003; Lencz et al., 2006). Similarly, data from the follow-up studies suggest that 
there is a deterioration of up to 10 points on IQ scores, after onset of psychosis, in a proportion of 
affected individuals (Aylward et al., 1984; Reichenberg et al., 2005, 2010). Recent studies of 
individuals at high risk of developing psychosis indicate that a significant proportion have problems 
with learning and have low IQ scores before the onset of illness (Keshavan et al., 2004, 2005; 
Johnstone et al., 2005). Some of the syndromes linked to ID have a strong association with 
schizophrenia (Shprintzen, 2008). 
The prevalence of schizophrenia and its correlates in the general population have been studied 
extensively. A systematic review of 188 studies from 46 countries examined the prevalence of 
schizophrenia in different populations, age groups and other strata. However, none of these studies 
have examined the prevalence of psychosis in individuals with ID (Saha et al., 2005). It is important 
to study the prevalence of psychosis in a population with ID because it can inform the service 
planning for this population as well as potentially help in understanding the biology of both 
schizophrenia and ID. Therefore, we aimed to systematically review the studies that examined the 
prevalence of psychosis in ID. 
Our aim was to determine the prevalence of psychosis in a population that had an existing diagnosis 
of ID. A longitudinal study design providing information on the time of onset of psychosis in 
individuals already diagnosed with ID would have best answered this question. However, only one 
study with a longitudinal design examined the development of psychosis in a cohort of individuals 
with ID. This review has relied on cross-sectional studies of populations with ID in whom the 
prevalence of psychosis was examined. 
Materials and methods 
We used the following inclusion criteria: 
(1) Studies reporting psychosis in a community or an institutional sample with ID. 
(2) ID diagnosed by an assessment of intelligence quotient and impaired adaptive functioning or 
assumed because individuals are in receipt of service for ID or live in an institution for populations 
with ID. 
(3) Studies reporting the prevalence of psychosis where the diagnosis of psychosis is made by a 
clinician or a standardized instrument is used to make a diagnosis. 
(4) Sample aged 14 years or older. 
We decided to include both community and institutional samples because individuals with ID lived in 
institutions during most of the 20th century, but toward the later part of the century, institutions 
were closed. ID is diagnosed using an intelligence quotient test and by assessment of adaptive 
functioning. In older studies, the intelligence quotient and adaptive functioning were not 
consistently reported and we believed that it was safe to assume that individuals living in ID 
institutions will have ID. Similarly, individuals receiving services for ID in the community go through 
an assessment and it is a reasonable assumption that they have ID. The practice of diagnosis of 
psychosis has changed over time and we have considered different methods used for diagnosis. We 
used a 14-year cut-off as autism was not well established as a diagnosis until recent decades. In the 
older studies from institutions, it could potentially be a confounder in younger age groups. 
Exclusion criterion was as follows: 
(1) Affective disorders apart from schizoaffective disorder were excluded. 
Search Strategy 
The initial searches were carried out using PsychINFO, MEDLINE and EMBASE from inception to 2 
October 2014. The following keywords were used for these searches: *schizophrenia, schizophrenia 
(disorganised type), or undifferentiated schizophrenia, or fragmentation schizophrenia or process 
schizophrenia or paranoid schizophrenia, or childhood schizophrenia or catatonic schizophrenia or 
acute schizophrenia and learning disability, learning difficulty, learning disorder, intellectual 
disability, intellectual difficulty, intellectual disorder, developmental disability, developmental 
difficulty, developmental disorder, mental retardation, mental handicap, mental disability, learning 
disabled, LD, learning impairment, developmental impairment, intellectual impairment, 
developmental delay, developmental disability. The full search strategy is available on request. 
We included studies that examined the prevalence of psychosis among individuals with an ID aged 
14 years or older. We used an inclusive definition of schizophrenia and learning disability as 
described below. We included studies that reported data both for children and for adults only when 
the data for populations of patients 14 years of age and older could be obtained separately. The 
population had to be representative of the ID population. Studies that described the prevalence of 
schizophrenia in a normal population and those with organic psychosis or brain injury were 
excluded. 
We used a two-stage process of exclusion; in the first stage, we looked at the title and abstracts and 
in the second stage we looked at full-text articles. We carried out a manual search of the references 
of the articles included to identify any additional relevant articles. Two authors (H.A. and M.A.) 
independently assessed the articles for inclusion and any disagreement was resolved through a face-
to-face discussion or additional advice from other authors (F.N. and S.F.). We contacted authors for 
additional information (Fig. 1). 
Description of intellectual disability 
We included all the studies of the prevalence of psychosis in which authors reported on populations 
with mental retardation, mental handicap, learning disability or ID. These studies cover the period 
from the mid-20th century onwards. Different methodologies were used to define these 
populations, which are further described in the Results section. 
Description of schizophrenia and psychosis 
We included all studies that reported schizophrenia or nonaffective psychoses. We looked at the 
description provided in the text for schizophrenia and nonaffective psychosis and used an inclusive 
approach. In our quality assessment, we reported the method used for the diagnosis  of ID as well as 
psychosis. 
Data extraction and analysis 
Once the study was included, we identified the total sample size and the number of affected 
individuals with psychosis. We also extracted information on the setting, year of publication and 
instruments used for the diagnosis of ID and psychosis. When studies only reported percentages, we 
calculated the numbers by utilizing the sample size and the percentage of affected individuals. 
We used the program Metafor implemented in R to calculate the effect size (Viechtbauer, 2010) and 
SE. We reported the effect size with a 95% confidence interval (CI). If the same data were reported 
in more than one publication, we selected the publication that had the most complete data. For 
assessment of the quality of the study, we examined a number of factors. In terms of the settings of 
the studies, we differentiated between the studies carried out in institutions and in a community. 
We expected many sources of heterogeneity in the studies because the methodology of assessment 
of ID and psychosis has evolved over the period covered by the studies. We used a random-effect 
model for meta-analysis because of heterogeneity. We examined the CIs in the forest plot for 
variability in the studies and we are reporting an I2 statistic as an indicator of heterogeneity. To 
explore systematic sources of heterogeneity, we carried out several sensitivity analyses. We 
investigated the effect of a number of factors: setting of the studies: community versus institutional 
studies, clinical diagnoses versus diagnoses on the basis of structured instruments and 
administrative samples versus samples where assessments were performed for the study. In each 
case, we carried out an analysis with one group of studies and noted the overlap in CIs in the effect 
size. In a second step, we investigated the effects of these factors as moderators in a mixed-effect 
model. To investigate the publication bias, we used a funnel plot. 
For assessment of quality, we did not use any summary measure; instead, we provide qualitative 
information on each study in the Supplementary Table S1 (Supplemental digital content 1, 
http://links.lww.com/PG/A154). 
Results 
We initially identified 1313 titles and abstracts. After excluding duplicates, 833 papers were 
examined. We identified 54 additional studies through a manual search. Of the total of 887 articles, 
we excluded 827 articles. We examined the full text of 60 articles and excluded 35 further articles. 
We contacted authors of five studies (Reiss, 1990; Rojahn et al., 1993; Cooper, 1997; Deb et al., 
2001; Morgan et al.,2008) for additional information. We could not obtain any additional 
information except for one study (Morgan et al., 2008). We used the email address supplied for one 
study, but the email message was not delivered (White et al., 2005). For eight older publications, it 
was not possible to contact the authors for a number of reasons, as either the contact information 
had changed or the authors had died or were not traceable (Wright, 1982; Day, 1985; Lund, 1985; 
Jacobson, 1990; Farmer et al., 1993; Patel et al., 1993; Sansom et al., 1994; Heaton-Ward, 1977). We 
used 25 articles with 27 datasets for this systematic review. 
Description of studies 
We could identify 25 studies with 27 datasets that fulfilled the inclusion criteria. All except one study 
(Al-Mutairi and Al-Mutairi, 2010) were from western industrialized nations. The study from Kuwait 
(Al-Mutairi and Al-Mutairi, 2010) was based on data from clients living in the community and 
attending day service. Twelve studies were carried out in the UK, two in Norway and three in 
Sweden. None of the studies were from low-income or middle-income countries. 
European Studies 
Five studies from the UK were carried out in Intellectual Disability Institutions (Reid, 1972; Heaton-
Ward, 1977; Wright, 1982; Day, 1985; Sansom et al., 1994). Two British studies were based on 
information from case registers (Farmer et al., 1993; Bhaumik et al., 2008). One study from the UK 
was based on a mixed hospital and a community sample for individuals from one geographical area 
(Corbett, 1979). Four studies from the UK were based on the data from community samples in the 
UK (Patel et al., 1993; Cooper, 1997; Deb et al., 2001; Cooper et al., 2007; Bhaumik et al., 2008). 
Two Swedish studies were based on data from community residents (Göstason, 1985; Nettelbladt et 
al., 2009) and the third one was based on a mixed sample of individuals residing in institutions and 
the community in a geographical area. This study was carried out at the time when the institutions 
were closing (Gustafsson and Sonnander, 2004). Two studies from Norway (Holden and Gitlesen, 
2004; Bakken et al., 2010) and one study from Denmark (Lund, 1985) were based on community 
samples. The study by Holden and Gitlesen (2004) did not include individuals with mild ID. 
Studies from the United States 
Three studies from the USA were based on administrative data of the community samples of 
individuals registered with the state-run services for disability (Jacobson, 1990; Rojahn et al., 1993; 
Clay and Thomas, 2005) and one study was based on individuals attending day programs (Reiss, 
1990).  
Australian studies 
One Australian study was based on state-run disability services administrative data (Morgan et al., 
2008). Another study from Australia was a subanalysis of National Psychiatric Morbidity surveys 
(White et al. 2005). 
Description of the sample 
There was a wide variation in the size of the samples. Twenty studies provide complete information 
on population and samples, which are described in Supplementary Table S1 (Supplemental digital 
content 1, http://links.lww.com/PG/A154). The study by White et al. (2005) was a sub-analysis of 
national survey and the total sample was not clearly provided; we estimated the sample from the 
total sample size and the percentage of ID information. In Morgan et al.’s (2008) study, we could 
separate and exclude the schizophrenia cases in the borderline ID range. 
The prevalence estimates 
The total sample in all studies providing information on the sample and population size was 140 189 
and 4292 individuals were affected. The estimated prevalence for all psychotic disorders in this 
population was 3.46% (95% CI: 2.51–4.42). Figure 2 shows the Forest plot of all the studies. 
Estimated heterogeneity was τ2=0.0002 (SE=0.001), τ was 0.0152, I2 was 97.87%, and Q (d.f.=26) 
was 2444.36, with P-value of less than 0.0001. This plot provides the diagnoses used by the authors. 
In 17 studies, the diagnosis was schizophrenia; in one study, the diagnosis was schizophrenia and 
delusional disorder. In three studies, the label used was psychosis, but from the description, it was 
clear that affective disorders were not included. In two studies, the diagnosis was schizophrenia and 
other psychotic disorders. These studies did not include affective disorders. One study was based on 
schizophrenia and schizoaffective disorder. 
Supplementary Table S2 (Supplemental digital content 1, http://links.lww.com/PG/A154) provides 
the different estimates of prevalence provided by the studies. There is a subanalysis of point 
prevalence and undefined prevalence. Eleven studies provided undefined prevalence rates (Reid, 
1972; Heaton-Ward, 1977; Day, 1985; Jacobson, 1990; Farmer et al., 1993; Rojahn et al., 1993; Clay 
and Thomas, 2005; Bhaumik et al., 2008; Morgan et al., 2008; Al-Mutairi and Al-Mutairi, 2010). The 
prevalence in these studies is estimated to be 3.30% (95% CI: 2.02–4.59). Eleven studies provided 
point prevalence and the cumulative prevalence in these studies is 3.75% (95% CI: 2.63–4.87) 
(Göstason, 1985; Lund, 1985; Reiss, 1990; Patel et al., 1993; Sansom et al., 1994; Cooper, 1997; Deb 
et al., 2001; Gustafsson and Sonnander, 2004; Holden and Gitlesen, 2004; Cooper et al., 2007; 
Bakken et al., 2010). One study provided cumulative lifetime incidence (Nettelbladt et al., 2009), one 
study provided the 6-month prevalence (White et al., 2005) and one study provided point as well as 
lifetime prevalence (Corbett, 1979). 
Prevalence in five high-quality studies 
Five studies were carried out in representative community samples using standardized instruments 
for diagnostic assessments (Göstason, 1985; Lund, 1985; Patel et al., 1993; Deb et al., 2001; Cooper 
et al., 2007). The prevalence estimate was 2.91 (95% CI: 1.38–4.44), I2 was 61.82% and Q (d.f. =4) 
was 12.3166, with P-value of 0.0151 (Fig. 3). 
Estimate of the prevalence of schizophrenia 
The meta-analysis in the general population was based on schizophrenia studies (Saha et al., 2005). 
We carried out a subanalysis of studies that had used schizophrenia as a diagnosis. Seventeen 
studies were included in this analysis. The prevalence estimate was 3.55% (95% CI: 2.66–4.44) (Fig. 
4). 
Prevalence in subpopulations 
Sex, intellectual disability and psychosis 
Supplementary Table S2 (Supplemental digital content 1, http://links.lww.com/PG/A154) provides 
information on the sex-wise distribution of psychosis. In nine studies, a separate distribution of men 
and women was available (Wright, 1982; Göstason, 1985; Lund, 1985; Jacobson, 1990; Sansom et al., 
1994; Cooper et al., 2007; Bhaumik et. al., 2008; Morgan et al., 2008; Al-Mutairi and Al-Mutairi, 
2010). The total sample of men was 28 830 and 1596 individuals were affected; the prevalence was 
estimated to be 3.78 (95% CI: 2.56–5.00). The sample size for women was 22 907, with 1208 of the 
participants being affected. The prevalence estimate in the female population was 4.10 (95% CI: 
2.86–5.35). 
Prevalence on the basis of the severity of intellectual disability 
The subanalysis on the basis of the level of ID is shown in Table 1. The degree of ID was not available 
in all studies. Information was available for mild ID in seven studies (Göstason, 1985; Lund, 1985; 
Sansom et al., 1994; Cooper et al., 2007; Bhaumik et al., 2008; Morgan et al., 2008; Al-Mutairi and 
Al-Mutairi, 2010), moderate ID for seven studies (Lund, 1985; Sansom et al., 1994; Cooper et al., 
2007; Bhaumik et al., 2008; Morgan et al., 2008; Al-Mutairi and Al-Mutairi, 2010) and severe ID for 
seven studies (Göstason, 1985; Lund, 1985; Sansom et al., 1994; Holden and Gitlesen, 2004; Cooper 
et al., 2007; Bhaumik et al., 2008; Morgan et al., 2008). The prevalence rates were as follows: mild 
ID: 514/7160, 5.55% (95% CI: 3.86–7.25); moderate ID: 179/4231, 4.21% (95% CI: 2.56–5.86) and 
severe ID: 53/3274, 0.89% (95% CI: 0.15–1.62).  
Quality assessments 
The validity of prevalence studies is a function of sampling and measurement methods (Boyle, 1998). 
We examined the measurement for the diagnosis of ID and schizophrenia, the expertise of the 
assessor in making a diagnosis, description of the method and the setting and year of publication. 
We describe the characteristics of the studies in Supplementary Table S3 (Supplemental digital 
content 1, http://links.lww.com/PG/A154), which provides indicators of the quality. The older 
studies were carried out in the hospitals. A number of studies have used administrative data from 
organizations providing services to ID population. There is a wide variation in the method of 
diagnosis of ID as well as psychosis. Because of these reasons, it is not possible to devise a 
quantitative score to summarize the quality of the studies. 
The studies used widely different methods for the diagnosis of ID and psychosis, and were carried 
out in a variety of different settings. 
Instruments/measures used for the diagnosis of intellectual disability 
The method is not described in four publications in any detail (Heaton-Ward, 1977; Wright, 1982; 
Sansom et al., 1994; Al-Mutairi and Al-Mutairi, 2010). Some studies utilized a standardized 
intelligence test or evaluation of adaptive functions and International Classification of Diseases, 10th 
revision (ICD-10) criteria (WHO, 1992) for diagnosis (Cooper et al., 2007; Bakken et al., 2011). 
Bhaumik et al. (2008) used diagnoses on the basis of a case register that uses the Disability 
Assessment Schedule (Holmes et al., 1982) to estimate the developmental age and WHO’s ICD-10 
criteria (WHO, 1992) for diagnosis. Clay and Thomas (2005) gathered information from patient 
records in an administrative database. In the database, the diagnosis of ID was established after 
cognitive and adaptive testing performed by a licensed psychologist for eligibility to receive the 
service. Few studies based their diagnoses on utilization of ID services (Corbett, 1979; Jacobson, 
1990; Reiss, 1990; Farmer et al., 1993; Cooper, 1997; Deb et al., 2001). Day used the ICD-9 (WHO, 
1975, p. 9) criteria for diagnoses using information in the patients’ records, including IQ (Day, 1985). 
In one study, psychological assessments were performed for the study (Göstason, 1985). Other 
methods were Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV) (American 
Psychiatric Association, 1994) criteria (Holden and Gitlesen, 2004), American Association on Mental 
Retardation criteria (Morgan et al., 2008), IQ assessment or a clinical evaluation using DSM-IV 
(American Psychiatric Association, 1994) criteria (Nettelbladt et al., 2009), multiple instruments 
(Patel et al., 1993) and information on IQ from patient records (Reid, 1972).  
In studies based on administrative data, information on ID was drawn from the records of the 
patients and in some studies, patients were assumed to have ID because they were receiving 
services. In some studies, it was supplemented by further assessments. In a small number of studies, 
new assessments were performed. We provide details in the Table S3 (Supplemental digital content 
1, http://links.lww.com/PG/A154), for each study.  
Instruments/measures used for the diagnosis of schizophrenia 
Usually establishment of a psychiatric diagnosis involves two steps: information gathering about the 
symptoms and use of a classification system for interpretation of that information to assign a 
diagnosis. In six studies, the clinical information was gathered through already available records 
(Jacobson, 1990; Farmer et al., 1993; Rojahn et al., 1993; Clay and Thomas, 2005; Bhaumik et al., 
2008; Morgan et al., 2008), whereas in nineteen studies, other assessments were completed for the 
purpose of the study. There was a variation in the information provided on the assessment methods 
in both the groups. We provide these details in the Table S3 (Supplemental digital content 1, 
http://links.lww.com/PG/A154), for each study. Some of the instruments used for information 
gathering were as follows: the Mini Psychiatric Assessment Schedule for Adults with Developmental 
Disability (Deb et al., 2001; Holden and Gitlesen, 2004) and the Psychiatric Assessment Schedule for 
adults with Developmental Disability (Patel et al., 1993; Deb et al., 2001), Psychiatric Present State – 
Learning Disability, a semistructure interview (Cooper et al., 2007), Diagnostic Assessment for the 
Severely Handicapped (Deb et al., 2001), Comprehensive Psychopathological Rating Scale (Göstason, 
1985), Psychopathology in Autism Checklist (Bakken et al., 2011), the Reiss Screen for Maladaptive 
Behaviour (Reiss, 1990; Gustafsson and Sonnander, 2004) and the MRC Schedule for Handicap, 
Behaviour and Skills (Lund, 1985). The classification system for diagnoses used included ICD-8 
(Corbett, 1979), ICD-10 (WHO, 1992) criteria (Deb et al., 2001; Bhaumik et al., 2008), ICD-9 (WHO, 
1975, p. 9) criteria (Reid, 1972; Morgan et al., 2008), DSMII (American Psychiatric Association, 1968; 
Jacobson, 1990), DSM-III (American Psychiatric Association, 1980; Göstason, 1985), DSM-III-R 
(American Psychiatric Association, 1987; Rojahn et al., 1993; Sansom et al., 1994; Gustafsson and 
Sonnander, 2004); and DSM-IV (American Psychiatric Association, 1994) diagnoses (Gustafsson and 
Sonnander, 2004 Al-Mutairi and Al-Mutairi, 2010). Cooper et al. 2007 used multiple criteria including 
ICD-10, DSMIV and DC-LD (Cooper et al., 2007). 
Sensitivity analysis 
Because of variations in the methodology, we carried out a series of sensitivity analyses to identify 
the effect of these variations on the results. Table 2 presents these results. There was a consistency 
in results and there was no systematic difference between community and institutional studies, 
clinical diagnoses versus diagnoses on the basis of structured instruments and administrative 
samples versus samples where assessments were performed for the study. Five hospital studies 
were all from the UK (Reid, 1972; Heaton-Ward, 1977; Wright, 1982; Day, 1985; Sansom et al., 
1994). Seven studies used diagnoses made by clinicians (Heaton-Ward, 1977; Wright, 1982; Day, 
1985; Farmer et al., 1993; Holden and Gitlesen, 2004; Clay and Thomas, 2005; Nettelbladt et al., 
2009). Six studies used administrative data or register data for diagnoses (Jacobson, 1990; Farmer et 
al., 1993; Rojahn et al., 1993; Clay and Thomas, 2005; Bhaumik et al., 2008; Morgan et al., 2008); in 
the rest of the studies, diagnoses were made for the purpose of the study. 
In categorical analysis of moderators, institutional versus community samples [QM (d.f.=1)=0.0781, 
P=0.7799], clinical diagnosis versus diagnosis on the basis of structured instruments [QM 
(d.f.=1)=0.1183, P=0.7309] and administrative samples versus samples where assessments were 
performed for the study [QM (d.f.=1)=0.4678, P=0.4940] were not significant. The factors that we 
investigated as possible causes of heterogeneity were not found to be significant contributors 
toward heterogeneity. 
Publication bias 
Funnel plot did not show the bias one would expect from the file-drawer problem. Publication bias is 
identified by a skew in the distribution toward higher effect sizes at the bottom of the funnel plot. 
The presence of this type of bias is not visually shown in our plot (Fig. 5). 
Discussion 
This is the first systematic review and meta-analysis of the prevalence of schizophrenia in 
populations with ID. Meta-analysis in the general population found a median lifetime morbid risk of 
0.72% (95% CI: 0.31–2.71). The point, period and lifetime prevalence figures were 0.6% (95% CI: 
0.19–1.0), 0.33% (95% CI: 0.13–0.82) and 0.40% (95% CI: 0.16–1.21), respectively (Saha et al., 2005).  
This indicates that prevalence rates of schizophrenia in the ID population are almost three times 
higher than those in the general population. The majority of the studies included in this review 
reported rates higher than those in the general population. Individuals with ID generally have 
problems in understanding their own symptoms and reporting those symptoms. The distress caused 
by the psychiatric symptoms may result in changes in behaviour, which is dismissed as 
an integral component of ID. These factors result in difficulties in the diagnosis of psychiatric 
disorders in this population. Reports from caregivers and observations on changes in behaviour are 
important tools for diagnostic assessment. Structured and semistructured instruments were 
developed later than those for the general population for the assessment of psychiatric syndromes 
in this population. Some of these instruments rely on reports from caregivers for severe and 
profound ID (Bamburg et al., 2001). There is evidence that some of the instruments developed for 
non-ID population can be used for this population (Hatton et al., 2005). Many instruments for 
populations with ID are now available (Melville, 2003) and more recent studies have used these 
instruments, but most of the older studies have used clinicians’ judgment as the main measure of 
diagnosis. Despite all these difficulties, most of the studies reported a prevalence higher than that in 
the general population. Administrative prevalence rates were in the same range as other studies and 
were generally based on a larger sample size. All these factors indicate that the higher rate of 
prevalence is a true finding. In line with the general population, prevalence estimates in the male 
and female populations were broadly similar. An interesting finding is a lower estimate in severe ID. 
We found that the mean prevalence rate was 5.55 (95% CI: 3.86–7.25) for mild ID, 4.21 (95% CI: 
2.56–5.86) for moderate ID, and 0.88 (95% CI: 0.15–1.62) for severe ID. The prevalence is similar in 
individuals with mild and moderate ID. The rate decreases for individuals with severe ID. There is 
more than one possible explanation for this difference. One possibility is that the lower rates are 
because of the difficulty in making a diagnosis of schizophrenia in individuals with a severe 
level of disability. This can also be linked to the nature of the underlying mechanism of association 
between the two disorders. For example, it is possible that if there is a common underlying genetic 
aetiology, this only affects individuals with mild/moderate ID and schizophrenia. Further research 
can help to unravel this issue. 
The higher prevalence of schizophrenia has implications for the practice and organization of services 
for individuals with ID and psychiatric disorders. Diagnostic overshadowing, where disturbed 
behaviours are assumed to be caused by ID and additional psychiatric diagnoses are missed, is a 
well-known phenomenon in this population (Reiss and Szyszko, 1983). Schizophrenia is a potentially 
treatable, although not curable disorder and effective treatments can help to prevent significant 
distress in a population that already has significant disability. 
It would be important to detect and treat the schizophrenia in this population. There is only one 
study outside the western industrialized nations. Considering that LAMI countries have more than 
three quarters of those affected with schizophrenia, there is a significant gap in this knowledge in 
the published literature. In most developing countries, there is a higher prevalence of ID because of 
increased prevalence of neurodevelopment disorders; thus, it is even more cause for concern. A few 
different mechanisms have been postulated as possible explanations for the association between ID 
and psychosis: common underling aetiology, deficits related to ID increase the risk of psychosis and a 
combination of ID and schizophrenia is a severe form of schizophrenia (Doody et al., 1998). These 
possibilities are not mutually exclusive. 
The strongest evidence is for a common aetiology both genetic and environmental in nature. A 
number of studies show considerable familiality across the two disorders. There are reports of 
increased rates of schizophrenia in families of probands with ID (Penrose, 1938; Gustavson et al., 
1986; Greenwood et al., 2004); ID in families of probands with schizophrenia (Heston, 1966; 
Modrzewska, 1980; Alaghband-Rad et al., 1998) and multiply affected families with co-occurring ID 
and schizophrenia (Penrose, 1938; O’Dwyer, 1997; Doody et al., 1998). A number of genetic 
syndromes with ID also have associated schizophrenia. Examples in this group are velocardiofacial 
syndrome 22q11.2 microdeletions  (Bassett and Chow, 1999; Schneider et al., 2014), fragile X 
syndrome (Gustavson et al., 1986), Klinefelter’s syndrome (Jablensky et al., 1970; DeLisi et al., 2005; 
Boks et al., 2007) and Dandy–Walker variant (Papazisis et al., 2007); copy number variants in many 
regions of the genome have been associated with both disorders (van Den Bossche et al., 2012; 
Derks et al., 2013). Evidence from epidemiological studies also supports a shared genetic risk for 
lower IQ and schizophrenia. In this respect, a recent study reported a dose–response relationship 
between low IQ and schizophrenia, and the strength of genetic effect increased with a decrease in 
IQ. It was absent in the high IQ range. This strongly points to a shared genetic aetiology (Kendler et 
al., 2015).  
In terms of environmental risk factors, obstetric complications have been reported to cause both 
schizophrenia and ID (Rosanoff et al., 1934; Cannon et al., 2002; Leonard and Wen, 2002). Changes 
in the intrauterine environment such as increased maternal cytokines resulting from hypoxia or 
infections can cause adverse neuropsychiatric outcomes that can involve both ID and schizophrenia 
(Brown, 2006; Meyer et al., 2007; Tsukimori et al., 2007). Similarly, increased levels of 
corticosteroids because of stress can result in the disruption of neurodevelopment (Goodyer et al., 
2001). The mechanisms by which these environmental insults effect the brain development are not 
well understood. Individuals with ID have difficulty in processing information and sometimes their 
disability involves emotional and social deficits. This increases their vulnerability to misperceive and 
misinterpret others (Crick and Dodge, 1994). They have fewer positive and rewarding relationships 
in life (Rosen and Burchard, 1990). They experience a variety of stresses (Bramston et al., 1999) 
and stigma and discrimination as a result of their ID (Pratt, 2009; Jahoda et al., 2010). The studies 
included in the review were carried out over the last 50 years. Many of the participants in these 
studies would have experienced institutional life. Increased vulnerability in terms of cognitive and 
emotional resources combined with increased levels of stressors can be another likely explanation 
for the association between ID and schizophrenia. 
There is some evidence from neuroimaging studies that the combination of schizophrenia and ID is a 
severe form of schizophrenia (Sanderson et al., 1999). The main strength of this systematic review is 
the historical depth of the datasets and the broadly similar prevalence across the majority of the 
studies, irrespective of the period, setting and methodology. There are a number of limitations in 
this study. Most of the studies have not reported separate prevalences in men and women and for 
different levels of disability. Populations from low-income and middle-income countries are not 
represented. There is a wide variation in the diagnostic methods used and also the settings of the 
studies. There is a variation in the sampling frame and methods because of changes in the way 
services are provided to the ID population and the living arrangement of individuals with ID 
(deinstitutionalization).  There is a significant geographical variation in the delivery of service and 
this is also reflected in the sampling method. On balance, we believed that it would be more useful 
to include all the studies and report the reason for the variation.  
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